Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy

By performing regular blood transfusion and iron chelation therapy, most patients with beta thalassemia major (BTM) now survive beyond the third decade of life. Liver disease is becoming an important cause of morbidity and mortality in these patients. Chronic hepatitis and/or severe iron overload ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Ashraf, Yassin, Mohamed, Al Yafei, Fawzia, Al-Naimi, Lolwa, Almarri, Noora, Sabt, Aml, De Sanctis, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010606/
https://www.ncbi.nlm.nih.gov/pubmed/24803998
http://dx.doi.org/10.4084/MJHID.2014.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010606/
https://www.ncbi.nlm.nih.gov/pubmed/24803998
http://dx.doi.org/10.4084/MJHID.2014.025

Ejemplares similares